3-(chloromethyl)-6-hydroxy-1-<(5,6,7-trimethoxyindol-2-yl)carbonyl>indoline | 130469-59-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(chloromethyl)-6-hydroxy-1-<(5,6,7-trimethoxyindol-2-yl)carbonyl>indoline
• 英文别名: 3-chloromethyl-6-hydroxy-1,2-dihydro-1-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]indoline；3-chloromethyl-6-hydroxy-1-(5,6,7-trimethoxyindole-2-carbonyl)indoline；(+)-seco-CI-TMI；3-(Chloromethyl)-6-hydroxy-1-((5,7-trimethoxyindol-2-yl)carbonyl)indoline；[3-(chloromethyl)-6-hydroxy-2,3-dihydroindol-1-yl]-(5,6,7-trimethoxy-1H-indol-2-yl)methanone
• CAS: 130469-59-9
• 化学式: C₂₁H₂₁ClN₂O₅
• 分子量: 416.861
• InChiKey: KFMLAUJMEDHHPN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  84
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-(chloromethyl)-6-hydroxy-1-<(5,6,7-trimethoxyindol-2-yl)carbonyl>indoline 、 sodium 生成 N-<(5,6,7-trimethoxyindol-2-yl)carbonyl>-1,2,7,7a-tetrahydrocycloprop<1,2-c>indol-4-one
  参考文献：
  名称：

  BOGER, DALE L.;ISHIZAKI, TAKAYOSHI;ZARRINMAYEH, HAMIDEH;MUNK, STEPHEN A.;+, J. AMER. CHEM. SOC., 112,(1990) N4, C. 8961-8971

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氯-3-硝基苯甲酸 在 platinum(IV) oxide 、 palladium on activated charcoal 盐酸 、 甲酸 、 氯化亚砜 、 sodium azide 、 硫酸 、 氢气 、 甲酸铵 、 sodium hydride 、 二异丁基氢化铝 、 sodium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 三苯基膦 、 lithium chloride 、 sodium nitrite 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 乙醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 生成 3-(chloromethyl)-6-hydroxy-1-<(5,6,7-trimethoxyindol-2-yl)carbonyl>indoline
  参考文献：
  名称：

  Nitrogen and sulfur analogues of the secoCI alkylating agent: Synthesis and cytotoxicity

  摘要：

  The first synthesis of seca-CI alkylating agents bearing a nitrogen or sulfur substituent in place of the oxygen at C-6 is described. In comparison with a phenol, an amino substituent confers reduced but significant cytotoxicity, even when mono- or dimethylated, while sulfur analogues are considerably less potent. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00507-0

文献信息

• Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs
  作者：Taeyoung Choi、Eunsook Ma

  DOI：10.1007/s12272-011-0302-1

  日期：2011.3

  A series of racemic indole C5-substituted seco-cyclopropylindoline compounds (2,3 and 5–7) were prepared by coupling 1-(tert-butyloxycarbonyl)-3-(chlorocarbonyl)indoline (seg-A) with 5,6,7-trimethoxy-, 5,6-dimethoxy-, 5-amino-, 5-methylsulfonylamino- and 5-(N,N-dimethylaminosulfonylamino) indole-2-carboxylic acid as seg-B in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. The synthetic compounds (2,3 and 5–7) were tested for cytotoxic activity against human cancer cell lines (COLO 205, SK-MEL-2, A549, and JEG-3) using the MTT assay.

  在 1-乙基-3-(3-二甲氨基丙基)碳二亚胺的存在下，将 1-(叔丁氧羰基)-3-(氯羰基)吲哚啉（sEG-A）与 5,6,7-三甲氧基-、5,6-二甲氧基-、5-氨基-、5-甲磺酰氨基-和 5-(N,N-二甲氨基磺酰氨基)吲哚-2-羧酸（sEG-B）偶联制备。采用 MTT 法测试了合成化合物（2、3 和 5-7）对人类癌细胞株（COLO 205、SK-MEL-2、A549 和 JEG-3）的细胞毒性活性。
• EFFICIENT SYNTHESIS OF (±)-seco-CYCLOPROPANEINDOLINE ANALOGS OF CC-1065
  作者：Sharon A. Jennings、James L. Toth、Shane G. Roller、Natalie Brooks、Caroline O'Hare、Konstantinos Kiakos、John A. Hartley、Philip J. Burke、Moses Lee

  DOI：10.1515/hc.2001.7.1.7

  日期：2001.1

  An efficient method for the preparation of racemic seco-cyclopropaneindoline, or seco-CI, analogs of the anticancer agent CC1065 is described. The syntheses of seco-CI compounds containing either 5,6,7-trimethoxyindole-2-carbonyl, 4, or 5-(benzofuran-2carboxamido)indole-2-carbonyl, 10, or 2-(4-N,N-diethyl)aminophenyl)benzimidazole-6carbonyl, 11, or 4-(4-butanamido-l-methylpyrrole-2-carboxamido)-l-

  描述了一种制备抗癌剂 CC1065 的外消旋 seco-环丙烷二氢吲哚或 seco-CI 类似物的有效方法。含有 5,6,7-三甲氧基吲哚-2-羰基、4 或 5-(苯并呋喃-2甲酰胺基)吲哚-2-羰基、10 或 2-(4-N,N-二乙基) 的 seco-CI 化合物的合成)氨基苯基)苯并咪唑-6羰基，11，或4-(4-丁酰氨基-1-甲基吡咯-2-甲酰胺基)-1-甲基吡咯-2-羰基，12，亚基。在μM浓度下，化合物4,10-12抑制培养中的人白血病K562细胞的生长。
• A strategy for tumor-selective chemotherapy by enzymatic liberation of seco-duocarmycin SA-derivatives from nontoxic prodrugs
  作者：Lutz F. Tietze、Monika Lieb、Tobias Herzig、Frank Haunert、Ingrid Schuberth

  DOI：10.1016/s0968-0896(01)00098-0

  日期：2001.7

  Immuno-conjugates obtained by linking enzymes with appropriate monoclonal antibodies, which bind to tumor-associated antigens, can be employed in a tumor-selective antibody directed enzyme prodrug therapy (ADEPT). For this strategy the glycosides 17a-c were prepared as prodrugs of CI-TMI 14 which is a structurally simplified analogue of the highly potent antitumor agent duocarmycin SA 2. Exposure of 17a-c to cultured carcinoma cells of line A549 displayed a very low toxicity; however, after addition of the corresponding enzymes and exposure for 24 h at prodrug concentrations of <0.1 M the proliferation of the carcinoma cells was inhibited almost completely with ED50prodrug/ED50drug of UP to 270 in the presence and in the absence of the enzyme. The synthesis of 17a-c was achieved by transformation of nitroanisidine 6 into 12 which was glycosidated to give 16a-c. Removal of the silyl groups, introduction of a chlorine atom and solvolysis of the acetal groups led to 17a-c, of which 17a and 17c are promising candidates for further elaboration. (C) 2001 Elsevier Science Ltd. All rights reserved.
• Duocarmycin-pyrindamycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the pharmacophore of the duocarmycin-pyrindamycin alkylation subunit. Identification of the CC-1065 duocarmycin common pharmacophore
  作者：Dale L. Boger、Takayoshi Ishizaki、Hamideh Zarrinmayeh、Stephen A. Munk、Paul A. Kitos、Oranart Suntornwat

  DOI：10.1021/ja00180a048

  日期：1990.11